The process of viral shedding and its relevance to effective screening for infectious disease.
Viral Shedding before and after symptom onset

The process of viral shedding and its relevance to effective screening for infectious disease.

The research paper, "Temporal dynamics in viral shedding and transmissibility of COVID-19", presents the process of viral shedding across the presymptomatic and symptomatic phases. The researchers provide significant insight into…

Continue Reading The process of viral shedding and its relevance to effective screening for infectious disease.

Evidence suggest 40+% of COVID cases can be traced to a presymptomatic individual, with high rates of transmission occurring two to three days prior to symptom onset.

The work by Xi He, et al appearing in the research paper titled "Temporal dynamics in viral shedding and transmissibility of COVID-19", which appeared in Nature Medicine (published April 15,…

Continue Reading Evidence suggest 40+% of COVID cases can be traced to a presymptomatic individual, with high rates of transmission occurring two to three days prior to symptom onset.

New England Journal of Medicine article details the challenges with symptom-based approaches to screening for COVID-19 in skilled nursing facilities.

"Presymptomatic SARS-COV-2 Infections and Transmissions in a Skilled Nursing Facility", The New England Journal of Medicine, Arons, et al, April 24, 2020 The research by Arons, et al establishes the…

Continue Reading New England Journal of Medicine article details the challenges with symptom-based approaches to screening for COVID-19 in skilled nursing facilities.

Hix Group brings the science of screening for epidemics to the U.S. market to help contain the spread of flu-like illnesses, including COVID-19.

BIRMINGHAM, Ala. and SAO PAULO, April 23, 2020 /PRNewswire/ -- Containing an invisible enemy, a pandemic virus, becomes increasingly difficult, if not impossible, when the virus can remain presymptomatic for…

Continue Reading Hix Group brings the science of screening for epidemics to the U.S. market to help contain the spread of flu-like illnesses, including COVID-19.